Azenta Announces the Election of Dipal Doshi to its Board of Directors
Press Releases
January 30, 2025

Azenta Announces the Election of Dipal Doshi to its Board of Directors

BURLINGTON, Mass., Jan. 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) and a recognized leader in the

bradford

The Bradford Era

Local & Social